Psychiatry and
Behavioral Sciences

Lorrin Koran

Publication Details

  • Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.

    Greist J, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, Rasmussen S, White K. Arch Gen Psychiatry. 1995; 52 (4): 289-95

    Anecdotal evidence suggests patients with obsessive-compulsive disorder (OCD) are treated with selective serotonin uptake inhibitors at dosages significantly higher than those used with depressed patients. The current study examined the efficacy, safety, and optimal dosing strategy of sertraline in patients with OCD.

    PubMedID: 7702445

Stanford Medicine Resources:

Footer Links: